Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy    crawled time : 12:05    save search
BioCryst Submits Marketing Authorization Application for UK Approval of ORLADEYO™ (berotralstat), an Oral, Once-daily Therapy to Prevent Attacks in Patients with Hereditary Angioedema
Published: 2021-03-02 (Crawled : 12:05) - globenewswire.com
BCRX | News | $4.385 -0.57% 3.4M twitter stocktwits trandingview |
Health Technology
 | | O: -1.42% H: 3.32% C: -0.59%
therapy approval authorized hereditary angioedema
Veru Expands Oncology Drug Pipeline; Exclusively Licenses Phase 3 Clinical Stage Targeted Therapy for Endocrine Resistant Metastatic Breast Cancer
Published: 2020-12-09 (Crawled : 12:05) - globenewswire.com
VERU | $1.27 0.0% 2.6M twitter stocktwits trandingview |
Health Technology
 | | O: 2.0% H: 28.31% C: 17.52%
breast cancer license cancer therapy endocrine drug phase 3 metastatic breast cancer
Gainers vs Losers
69% 31%

Top 10 Gainers
ACLX | $55.0 5.77% 260K twitter stocktwits trandingview |

MTTR | News M | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.99 139.2% 64M twitter stocktwits trandingview |
Finance
EDBL | News | $6.47 72.07% 1.9M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services
AEON | $4.235 -10.27% 66K twitter stocktwits trandingview |

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance
SHIM | $3.05 35.56% 26.23% 870K twitter stocktwits trandingview |

HKIT | $1.345 31.86% 380K twitter stocktwits trandingview |
Technology Services
OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

Your saved searches
Save your searches and get alerts when important news are released.